AbbVie has decided against progressing a recommendation by the Pharmaceutical Benefits Advisory Committee for the listing of VENCLEXTA (venetoclax). …
New Stories
-
Government delays new cost-recovery model
May 24, 2018 - - Latest News -
Positive news for Australian company Actinogen
May 24, 2018 - - Latest News -
US company decides not to match Sirtex bid
May 24, 2018 - - Latest News -
BMS updates Study Connect website
May 24, 2018 - - Latest News -
US Congress backs 'right-to-try' law
May 24, 2018 - - Latest News -
ASMI urges backing for legislation
May 23, 2018 - - Latest News -
Recognition for Swisse
May 23, 2018 - - Latest News